Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
LIMK1 Blocking Peptide (AC1238)
Cat.#: ACPP-1238
Specifications
Despition LIMK1 Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1279 NEDD4 Blocking Peptide (AC1279) 250 µg inquiry ACPP-1414 Human BEX1 Protein (AC1414) 2 µg inquiry ACPP-1835 Human RP9 Protein (AC1835) 5 µg inquiry ACPP-1671 Human SPINT2 Protein, Sf9 (AC1671) 2 µg inquiry ACPP-1601 Rat ACRP30 Protein (AC1601) 2 µg inquiry ACPP-1050 Recombinant Human LIF Protein (Fc Tag) (AC1050) 50 µg inquiry ACPP-1432 Human NENF Protein (AC1432) 2 µg inquiry ACPP-1271 Alpha Synuclein Blocking Peptide (AC1271) 250 µg inquiry ACPP-1001 Recombinant Human DEGA Protein (6×His Tag) (AC1001) 50 µg inquiry ACPP-1294 DCC Blocking Peptide (AC1294) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket